| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |